Search Results for 'hcv week'

hcv week published presentations and documents on DocSlides.

Management of HCV in Co-Infected Patients
Management of HCV in Co-Infected Patients
by danika-pritchard
Marie-Louise Vachon, MD, . MSc. Division of . Inf...
Future HCV Treatment Paradigms
Future HCV Treatment Paradigms
by kittie-lecroy
Mark Sulkowski, MD . Professor of Medicine. Medic...
3 D (Paritaprevir-Ritonavir-Ombitasvir
3 D (Paritaprevir-Ritonavir-Ombitasvir
by aaron
. + Dasabuvir) + RBV in GT1 . TURQUOISE-I. Phase...
TURQUOISE-I:
TURQUOISE-I:
by tawny-fly
SAFETY AND EFFICACY OF ABT-450/R/OMBITASVIR, DASA...
Edited by
Edited by
by luanne-stotts
Morris Sherman MD . BCh. PhD FRCP(C) . Associate...
Boceprevir in Treatment Experienced
Boceprevir in Treatment Experienced
by tatiana-dople
RESPOND-2. Phase . 3. Treatment. . Experienced. ...
Current strategies for the management of treatment naïve a
Current strategies for the management of treatment naïve a
by min-jolicoeur
Mark S. Sulkowski, MD. Medical Director, Viral He...
Edited by
Edited by
by celsa-spraggs
Morris Sherman MD . BCh. PhD FRCP(C) . Associate...
Treatment of Hepatitis C in patients with
Treatment of Hepatitis C in patients with
by tatyana-admore
thalassaemia. . Where . are we now?. Telaprevir ....
Direct Acting Antivirals:  What are they?  What is their pl
Direct Acting Antivirals: What are they? What is their pl
by tawny-fly
Mark Sulkowski, MD. Associate Professor of Medici...
Daclatasvir in Combination With Sofosbuvir
Daclatasvir in Combination With Sofosbuvir
by mitsue-stanley
With Or Without Ribavirin Is Safe and Efficacious...
PEG alfa-2a +
PEG alfa-2a +
by tawny-fly
RBV . versus. . PEG alfa-. 2a . versus. INF + R...
Daclatasvir in Combination With Sofosbuvir
Daclatasvir in Combination With Sofosbuvir
by mitsue-stanley
With Or Without Ribavirin Is Safe and Efficacious...
Peginterferon alfa-2a +
Peginterferon alfa-2a +
by stefany-barnette
RBV . versus. Interferon alfa. -. 2a + RBV . ACT...
PEG alfa-2a    RBV  versus
PEG alfa-2a RBV versus
by alexa-scheidler
. PEG alfa-. 2a . versus. INF RBV . APRICOT S...
Practical management of PI therapy
Practical management of PI therapy
by TropicalParadise
in Hepatitis C . Paris . Februari. 2012. Ola . We...
Peginterferon alfa-2a (
Peginterferon alfa-2a (
by tatyana-admore
Pegasys. ). Prepared by: David Spach, MD & H....
Edited by
Edited by
by ellena-manuel
Morris Sherman MD . BCh. PhD FRCP(C) . Associate...
EFFICACY AND SAFETY OF THE INTERFERON-FREE COMBINATION OF
EFFICACY AND SAFETY OF THE INTERFERON-FREE COMBINATION OF
by hezekiah
FALDAPREVIR (BI 201335) + BI 207127 ± RIBAVIRIN. ...
Safety and Efficacy of  Daclatasvir
Safety and Efficacy of Daclatasvir
by tabitha
. Plus . Sofosbuvir. With or Without Ribavirin . ...
How to optimize treatment of G1 patients?
How to optimize treatment of G1 patients?
by KissesForYou
Prof. G. K. K. Lau 2012. Standard of care (SOC) ...
NS5A and polymerase inhibitors
NS5A and polymerase inhibitors
by LoveBug
Mark Sulkowski, MD. Professor of Medicine. Johns H...
Are (exogenous)  interferons
Are (exogenous) interferons
by amey
really necessary?. Peter . Ferenci. Medical Univer...
M.W. Fried , 1  M. Buti,
M.W. Fried , 1 M. Buti,
by iamamercy
2. G.J. Dore,. 3. P. Ferenci,. 4. . I. Jacobson...